Drug recall D-0262-2024

Class II Terminated reported Jan 31, 2024

Product

Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.

Reason for recall

Lack of Sterility Assurance: Aseptic process simulation failure.

Lots and codes

lot #13D012AA, Exp: 08/31/2025

Recall details

Recalling firm
BE PHARMACEUTICALS AG, Zug, N/A
Quantity
22,176 Vials
Distribution
Nationwide in the USA
Type
Voluntary: Firm initiated
Recall initiated
January 10, 2024
Terminated
June 10, 2025

Related products